Dr. Marc H. Levin, MD

Dr. Levin practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Levin's NPI, 1811123441, was assigned on June 10, 2009. Dr. Levin graduated from University of California (San Francisco) School of Medicine in 2008. Dr. Levin's Pennsylvania license number on file is MD445137.

Dr. Levin's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Levin's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Levin to 3 more group practices and clinics, 3 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levin practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Levin's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Levin is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Levin's licenses on file in 2 states: Pennsylvania and California.

Dmand AI lists dry eye, glaucoma, shingles and vision problems among the conditions Dr. Levin treats.

CMS data shows 403 Medicare services from Dr. Levin across 7 procedure codes in 2024, for 211 Medicare patients. Medicare paid $23,085 for them.

CMS counts 211 Medicare patients who saw Dr. Levin in 2024. The largest group is 65 to 74, with 98 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 11% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Levin's median patient age at 71, with 56% women.

In 2024, Dr. Levin wrote 109 Medicare Part D claims for 49 patients. 81% of them were for generic drugs. CMS names the drug for 64 of them, across 4 drugs with 11 or more claims each, at $1,982 in total drug cost. In 2023, CMS named 132 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Levin for performance year 2024, reported as part of a group. Dr. Levin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 51 papers to Dr. Levin, published from 2001 to 2024. 2016 was the busiest year, with 7. The most frequent topics are Aquaporins, Cystic Fibrosis Transmembrane Conductance Regulator and Retina. Dr. Levin has published most often in Invest Ophthalmol Vis Sci. Dr. Levin's most frequent co-authors are Christian Manuel Felix, Onur Cil, MD, PhD and Steven L. Galetta, MD.

Dmand AI links Dr. Levin to 1 clinical trial. Conditions studied include Anisometropia and Strabismus.

CMS Open Payments shows 29 general payments to Dr. Levin from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 99% of the total. Jazz Pharmaceuticals Inc. paid the most, $53,000. It also lists 86 research payments totaling $335,879 from 2017 to 2025.

Dr. Levin graduated from University of California (San Francisco) School of Medicine in 2008.

Dr. Levin is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.